About this file

The provided document is a price list for an immunohistochemistry (IHC), in-situ hybridization (ISH), and special staining system. It lists a variety of products and associated pricing, delivery, and contact information for VA Palo Alto Health Care System. The related federal contract opportunity is a solicitation (36C26124Q0938) for a cost per test (CPT) bridge for these IHC, ISH, and special staining products and services. The contract period is from 10/1/24 to 3/31/25, with delivery to the VA Palo Alto Health Care System. The solicitation is being issued by the Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 21.

View the file

Other files

File Type Posted
36C26124Q0938.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Items

Item NumberDescriptionContract PeriodPop BeginPop EndQuantityUnit of MeasureUnit PriceItem Discount Type NameItem DiscountAddress1Address2Address3CityStateZipZip4CountryDelivery DateFOB
0001AMPLIFICATION KIT, CEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0002ANTIBODY DILUENTBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0003Antibody Dilution Buffer (250ml)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0004BLUING REAGENTBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0005ENDOGENOUS BIOTIN BLOCKING KIT, CEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0006HEMATOXYLINBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0007Hematoxylin IIBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0008NeuVision Blocking ReagentBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0009NeuVision Nuclear Stain KitBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0010OptiView Amplification KitBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0011OptiView Amplification Kit (250)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0012PROTEASE 1Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0013PROTEASE 2Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0014PROTEASE 3Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0015Ventana Antibody Diluent with CaseinBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0016CINtec Wash Buffer 10XBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0017VENTANA Protease Neg Reagent Control-IVDBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0018CONFIRM ANTI-ER (SP1)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0019CONFIRM ANTI-ER (SP1) PRIMARY ANTIBODY (Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0020CONFIRM ANTI-KI-67 (30-9) RABBIT MONOCLOBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0021CONFIRM ANTI-PR (1E2)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0022CONFIRM ANTI-PR (1E2) 250Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0023CONFIRM ANTI-P53 (DO-7)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0024PATHWAY ANTI-HER-2/NEU (4B5) RABBIT MONOBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0025VENTANA ALK (D5F3) CDx AssayBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0026ASSY, Kit Pack, Pathway C-KitBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0027VENTANA PD-L1 (SP142) CDx AssayBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0028VENTANA PD-L1 (SP263) Rabbit Pab PMBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0029VENTANA H. PYLORI (SP48) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0030VENTANA H. PYLORI (SP48) PAB 250Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0031VENTANA PD-L1 (SP263) Rabbit Monoclonal PrimaryBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0032VENTANA PTEN (SP218) AssayBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0033CINtec Histology (50 tests)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0034CINtec Histology (250 tests)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0035VENTANA DLL3 (SP347) AssayBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0036ANTI-MLH1 (M1) Mouse Monoclonal PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0037MSH6 (SP93) Rabbit Monoclonal PAB USBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0038MSH2 (G219-1129) Mouse Monoclonal PAB USBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0039PMS2 (A16-4) Mouse Monoclonal PAB USBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0040BRAF V600E (VE1) Mouse Monoclonal PAB USBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0041VENTANA HA AssayBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0042PSMA (EP192) PAb, Cell MarqueBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0043CA IX (EP161) PAb, Cell MarqueBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0044CELL MARQUE, INSULINBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0045Inhibin, alpha (MRQ-63) PAb, Cell MarqueBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0046MUM1 (EP190) PAb, Cell MarqueBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0047VENTANA MSLN (SP74) AssayBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0048ANDROGEN RECEPTOR (SP107) CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0049ANNEXIN A1 (MRQ-3) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0050ANTI-CD30 (BER-H2)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0051ANTI-CD43 (L60) PRIMARY ANTIBODYBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0052Anti-CEA (TF-3H8-1) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0053Anti-CHROMOGRANIN A (LK2H10) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0054ANTI-HENT1 SP120Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0055VENTANA CLDN18 (43-14A) ASSAYBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0056Anti-Keratin, Pan (AE1/AE3 & PCK26) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0057anti-p40 (BC28) Mouse Monoclonal PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0058ANTI-P53 (Bp53-11) PaBBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0059ANTI-PAN KERATIN PRIMARY ANTIBODY, 25 MLBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0060ARGINESE-1 (SP1546) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0061ASSY, CONFIRM Anti-EGFR (3C6), IVDBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0062bcl-2 (SP66) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0063BG8 LEWIS Y (F3) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0064BOB.1 (SP92) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0065C3d (POLYCLONAL) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0066C4d (Polyconal)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0067C4d (SP91)PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0068CADHERIN 17 (SP183) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0069CALCITONIN (SP17) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0070Caldesmon (E89) PAb, Cell MarqueBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0071Calponin-1 (EP798Y) PAb, Cell MarqueBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0072Caveolin1 (SP43) PAb, Cell MarqueBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0073CD13 (SP187) PRIMARY PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0074CD-138 (B-A38) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0075CD14 (EPR3653) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0076CD16 (SP175) PRIMARY PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0077CD163 (MRQ-26) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0078CD1a (EP3622) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0079CD2 (MRQ-11) PAb, Cell MarqueBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0080CD21 (EP3093) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0081CD22 (SP104) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0082CD25 (4C9) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0083CD31 (JC70) PAb, Cell MarqueBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0084CD33 (SP266) PAb, Cell MarqueBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0085CD38 (SP149) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0086CD44 (SP37) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0087CD56 (MRQ-42) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0088CD63 (NKI/C3) PAb, Cell MarqueBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0089CD7 (SP94) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0090CD71 (MRQ-48) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0091CDX-2 (EPR2764Y) PAb, Cell MarqueBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0092CEA (CEA31) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0093CELL MARQUE REAGENT, ALPHA-FETOPROTEINBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0094CELL MARQUE, A-1-ANTICHYMOTRYPSINBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0095CELL MARQUE, A-1-ANTITRYPSINBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0096CELL MARQUE, BCA-225Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0097Cell Marque, bcl-6Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0098Cell Marque, Beta-CateninBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0099CELL MARQUE, CA-125Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0100CELL MARQUE, CA19-9Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0101CELL MARQUE, CALCITONINBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0102Cell Marque, CD21 (2G9)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0103CELL MARQUE, CD34Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0104Cell Marque, CD45 (2B11 & PD7/26)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0105CELL MARQUE, CD45RBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0106CELL MARQUE, CD57Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0107Cell Marque, CD61Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0108CELL MARQUE, CK,35 BETAH11Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0109CELL MARQUE, COLLAGEN TYPE-IVBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0110Cell Marque, COX-2 (SP21)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0111Cell Marque, Cytokeratin 19Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0112CELL MARQUE, FACTOR 8-R AG.Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0113Cell Marque, Galectin-3 (9C4)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0114CELL MARQUE, GASTRINBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0115CELL MARQUE, GLUCAGONBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0116Cell Marque, Glycophorin ABase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0117Cell Marque, Granzyme B (P)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0118CELL MARQUE, HCGBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0119CELL MARQUE, IGABase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0120CELL MARQUE, IGGBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0121CELL MARQUE, IGMBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0122CELL MARQUE, LYSOZYMEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0123CELL MARQUE, MACROPHAGEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0124Cell Marque, MammaglobinBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0125CELL MARQUE, MUSCLE SPECIFIC ACTINBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0126CELL MARQUE, MYELOPEROXIDASEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0127CELL MARQUE, MYOGLOBINBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0128CELL MARQUE, NEUROFILAMENTBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0129Cell Marque, p27 (SX53G8)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0130CELL MARQUE, PLAPBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0131Cell Marque, PSA (ER-PR8)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0132Cell Marque, PSAP (PASE/4LJ)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0133Cell Marque, Renal Cell CArcinoma(PN-15)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0134CELL MARQUE, SOMATOSTATINBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0135Cell Marque, SpectrinBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0136CELL MARQUE, TAG-72Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0137CELL MARQUE, TDTBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0138CELL MARQUE, THYROGLOBULINBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0139Cell Marque, TRAcP (9C5)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0140Cell Marque, Tryptase (G3)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0141Cell Marque, Villin (CWWB1)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0142Cell Marque, ZAP-70 (2F3.2)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0143CK 5 (SP27) PAb, Cell MarqueBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0144CK 5/14 (EP1601Y/LL002) PAb, Cell MarqueBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0145CK14 (SP53) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0146c-MYC (Y69) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0147CONFIRM anANTI-ACTIN MUSCLE (HUC1-1) PaBBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0148CONFIRM anti MITF C5/D5 mouse monoBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0149CONFIRM anti-ALK1 (ALK01)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0150CONFIRM anti-CD15 (MMA) PAB, IVDBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0151CONFIRM anti-CD20 (L26) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0152CONFIRM anti-CD23 (SP23) Rabbit MonoclonBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0153CONFIRM anti-CD3 (2GV6) Rabbit MonoclonaBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0154CONFIRM anti-CD34 (QBEnd/10) Primary AntBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0155CONFIRM Anti-CD4 (SP35) Rabbit MonoBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0156CONFIRM anti-CD45 (LCA) (RP2/18) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0157CONFIRM anti-CD45RO (UHCL-1) Primary AntBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0158CONFIRM anti-CD5 (SP19) Rabbit MonoBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0159Confirm anti-CD56 (123C3) mABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0160CONFIRM anti-CD68 (KP-1) Primary AntibodBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0161Confirm anti-CD99 Mouse MonoBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0162CONFIRM Anti-c-MET (SP44) RbmAbBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0163CONFIRM ANTI-CYTOKERATIN (AE1) PaBBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0164CONFIRM anti-Desmin (DE-R-11) PAbBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0165CONFIRM ANTI-EGFR (5B7) RABBIT MONOCLONABase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0166CONFIRM ANTI-IGF-1R (G11) RABBIT MONOCLOBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0167CONFIRM anti-Kappa Rabbit Polyclonal PriBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0168CONFIRM anti-Keratin (34E12) Mouse MonoBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0169CONFIRM Anti-Keratin (AE3) Primary AntibBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0170CONFIRM anti-Lambda Rabbit Polyclonal PrBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0171CONFIRM anti-LMO2 (1A9-1) Monoclonal PrBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0172CONFIRM anti-Melanosome (HMB45) Mouse MBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0173Confirm Anti-PAX5 (SP34) Rabbit MonoBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0174CONFIRM ANTI-PSA (polyclonal) Primary AnBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0175CONFIRM anti-S100 (4C4.9) Primary AntiboBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0176CONFIRM anti-S100 (polyclonal) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0177CONFIRM anti-Synaptophysin (SP11) RabbitBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0178CONFIRM anti-Thyroid transcription factBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0179CONFIRM anti-Topoisomerase II (JS5B4)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0180CONFIRM anti-Tyrosinase (T311) Mouse MonBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0181CONFIRM Anti-Vimentin (V9) Primary AntibBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0182CONFIRM anti-Vimentin (Vim 3B4) PrimaryBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0183CONFIRM bcl-2 (124) MabBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0184CONFIRM Calretinin (SP65) RbmAbBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0185CONFIRM CD79a RabbitMonoBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0186CONFIRM CD8 (SP57) RabbitMonoBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0187CONFIRM Cytokeratin 20 Rabbit MonoBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0188CONFIRM Cytokeratin7 RabbitMonoBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0189CONFIRM EMA (E29) Mouse mAbBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0190CONFIRM MART-1/melan A (A103) Primary AnBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0191CONFIRM Neg. Contr. Rabbit IgBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0192Confirm TP (P-GF.44C) MabBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0193Cytokeratin (CAM 5.2) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0194Cytokeratin (D5/16B4) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0195Cytokeratin 10 (SP99) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0196Cytokeratin 14 (LL002)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0197Cytokeratin 17 (SP95) PABBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0198CYTOKERATIN8&18(B22.1&B23.1 CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0199DESMOGLEIN-3 (5G11) PAB, CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0200DOG-1 (SP31) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0201E CADHERIN (EP700Y) PAb CELL MARQUEBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0202EGFR del (SP111)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0203EGFR L858R (SP125)Base10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION
0204EP-CAM (Ber-EP4) PAb, Cell MarqueBase10/1/243/31/251EAPercent0VA Palo Alto Health Care SystemATTN: Pathology & Laboratory Medicine Service3801 Miranda Ave, Bldg. 100 E4-319Palo AltoCA94304USA10/01/2024 - 03/31/2025DESTINATION

This is the start of the file's text. The full file is on GovTribe.

File details come from the government source that posted it. Updated .